Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT02425527
Eligibility Criteria:
Inclusion Criteria:
* Adults with age of 18 - 65 years
* Diagnosis of traumatic brain injury (diagnostic criteria ICD-10, S06.X, T90.5)
* Having TV screen, computer and internet access at home
* No active digital play gamer (5 hours or less/a week)
* Able to understand, speak and/or read Finnish language
* Willing to participate in the study based on their own free will (a signed written informed consent form)
* Discharged from the neurologic treatment period due to traumatic brain injury over 12 months before possible recruitment
* No active participation in cognitive rehabilitation during the last 3 months
Exclusion Criteria:
* Age below 18 years or over 65 years of old
* Active digital game player (over 5 hours/a week)
* Sensory, cognitive or physical (severe cognitive impairment, deficiency preventing the use of regular computers unaided or computer game control system (impairment in vision, severe astigmatism, hemiplegia, disorder in visuospatial perception, dysfunction of the central vestibular system)
* Inability to understand, speak and/or read Finnish language
* Apathy identified in previous neuropsychological evaluations
* Diagnosed severe mental disorders (e.g. schizophrenia or severe depressive disorders to be identified as the secondary diagnosis)
* Unwillingness and/or incapability to participate in the study
* Active cognitive rehabilitation during the last 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02425527
Study Brief:
Protocol Section:
NCT02425527